The biggest and most up-to-date study by Beije et al. [105,106,107,108,109] did not show either predictive or prognostic role of ER or HER2 status in 154 patients with metastatic IBC and this was confirmed by other reports [93,101,103,105]. This evidence concerns the gene ERBB2 and inflammatory breast carcinoma.